SEC Form 4 · accession 0001477932-17-000127
Nascent Biotech Inc. · NBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brandon Price
Officer — Senior VP Business Development · Director · 10% Owner
Period of report
Dec 30, 2016
Accepted (ET)
Jan 9, 2017 · 8:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001622057
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 30, 2016 | J | 7,800 | $0.35 | A | 927,487 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were granted as part of the employment contract with the Company.